Evolution in the resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Nicaragua

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 1, 2009, Pages 62-67

  Chacon L ^a   Lainez, M ^a   Rosales, E ^a   Mercado, M ^a   Caminero, Jose A ^b,c  

^a Departemento de Micobacterias   (Nicaragua)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^c INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

Author keywords

Initial resistance; MDR TB; Multidrug resistance; Nicaragua

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SHORT COURSE THERAPY; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MICROBIAL; HEALTH SURVEYS; HUMANS; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; NICARAGUA; PREVALENCE; STREPTOMYCIN; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 58149380388     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Zignol M, Hosseini M S, Wright A, et al. Overall incidence of multidrug-resistant tuberculosis. J Infect Dis 2006; 194: 479-485.
2. World Health Organization. The WHO/IUATLD Overall Project on Anti-tuberculosis Drug Resistance Surveillance. Antituberculosis drug resistance in the world. Report no. 3. WHO/CDS/TB/2004.343. Geneva, Switzerland: WHO, 2004.
3. World Health Organization. The overall MDR-TB and XDR-TB response plan 2007-2008. WHO/HTM/STB/2007.2007.387. Geneva, Switzerland: WHO, 2007.
4. World Health Organization. Overall tuberculosis control: surveillance, planning, financing. WHO report 2007. WHO/HTM/TB/2007.376. Geneva, Switzerland: WHO, 2007.
5. Caminero J A. Likelihood of generating multidrug-resistant and extensively drug-resistant tuberculosis under the National Tuberculosis Programme conditions. Int J Tuberc Lung Dis 2008; 12: 869-877.
6. Aguillar R, Garay J, Villatoro M, et al. Results of a national study on anti-mycobacterial drug resistance in El Salvador. Int J Tuberc Lung Dis 2005; 9: 514-520.
7. Aristimuño L, Armengol R, Cebollada A, et al. Molecular characterisation of Mycobacterium tuberculosis isolates in the first national survey of anti-tuberculosis drug resistance from Venezuela. BMC Microbiol 2006; 6: 90.
8. World Health Organization. Framework for effective tuberculosis control. WHO/TB/94.179. Geneva, Switzerland: WHO, 1994: pp 1-7.
9. World Health Organization. The WHO/IUATLD Overall Project on Anti-tuberculosis Drug Resistance Surveillance. Antituberculosis drug resistance in the world. Report no. 2. Prevalence and trends. World Health Organization Document 2000. WHO/ CDC/TB/2000.278. Geneva, Switzerland: WHO, 2000.
10. Heldal E, Arnadottir T, Cruz J R, Tardencilla A, Chacon L. Low failure rate in standardised retreatment of tuberculosis in Nicaragua: patient category, drug resistance and survival of 'chronic' patients. Int J Tuberc Lung Dis 2001; 5: 129-136.
11. Chacon L, Laszlo A, Lainez M, Rosales E. Estudio nacional de resistencia inicial en Nicaragua, 1997 [abstract]. Int J Tuberc Lung Dis 1999; 3 (Suppl 1): S116. [Spanish]
12. World Health Organization. Guidelines for the surveillance of drug resistance in tuberculosis. World Health Organization Document 2003. WHO/TB/2003.320 Geneva, Switzerland: WHO, 2003.
13. Canetti G, Froman S, Grosset J, et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 1963; 29: 565-578.
14. Ministerio de Salud Nicaragua. Informe Anual del Programa Nacional de Control de la Tuberculosis. XIV edición 2004. Managua, Nicaragua: Ministerio de Salud, 2005. [Spanish]
15. Trébucq A, Anagonou S, Gninafon M, Lambregts K, Boulahbal F. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Benin after 12 years of short-course chemotherapy. Int J Tuberc Lung Dis 1999; 3: 466-470.
16. Montoro E, Lemus D, Echemendia M, et al. Drug-resistant tuberculosis in Cuba. Results of the three overall projects. Tuberculosis 2006; 86: 319-323.
17. Valenzuela P, Piffardi S, Lepe R, Velasco M. Panorama actualizado de la resistencia a fármacos antituberculosos. Chile - 1998. Rev Chil Infect 1998; 15: 225-233. [Spanish]
18. Githui W A, Juma E S, van Gorkom J, Kibuga D, Odhiambo J, Drobniewski F. Anti-tuberculosis drug resistance surveillance in Kenya, 1995. Int J Tuberc Lung Dis 1998; 2: 499-505.
19. Githui W A, Hawken M P, Juma E S, et al. Surveillance of drug-resistant tuberculosis and molecular evaluation of transmission of resistant strains in refugee and non-refugee populations in North-Eastern Kenya. Int J Tuberc Lung Dis 2000; 4: 947-955.
20. Kruuner A, Sillastu H, Danilovitsh M, et al. Drug-resistant tuberculosis in Estonia. Int J Tuber Lung Dis 1998; 2: 130-133.
21. Heldal E, Cruz J R, Arnadottir T, Tardencilla A, Enarson D A. Successful management of a National Tuberculosis Programme under conditions of war. Int J Tuberc Lung Dis 1997; 1: 16-24.
22. Marrero A, Caminero J A, Billo N E. Towards elimination of tuberculosis in a low income country: the experience of Cuba, 1962-1997. Thorax 2000; 55: 39-45.
23. Rusen I D, Aït-Khaled N, Alarcón E, et al. Cochrane systematic review of directly observed therapy for treating tuberculosis: good analysis of the wrong outcome. Int J Tuberc Lung Dis 2007; 11: 120-121.
24. Jindani A, Nunn A J, Enarson D A. Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial. Lancet 2004; 364: 1244-1251.
25. Kritski A L, Rodrigues de Jesus L S, Andrade M K, et al. Retreatment tuberculosis cases. Factors associated with drug resistance and adverse outcomes. Chest 1997; 111: 1162-1167.
26. Yoshiyama T, Yanai H, Rhiengtong D, et al. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes. Int J Tuber Lung Dis 2004; 8: 31-38.
27. Saravia J C, Appleton S C, Rich M L, Sarria M, Bayona J, Becerra M C. Retreatment strategies when first-line tuberculosis therapy fails. Int J Tuberc Lung Dis 2005; 9: 421-429.
28. World Health Organization. Guidelines of the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/2006.361. Geneva, Switzerland: WHO, 2006.